Business News›Industry›Healthcare/Biotech›Pharmaceuticals›Prices of anti-diabetics and some cancer drugs likely to be capped
Prices of anti-diabetics and some cancer drugs likely to be capped
Synopsis
India may mandate a cut in prices of some cancer drugs, anti-diabetics and medicines for thyroid, as the government inches closer to updating the list of essential medicines and bringing some of them under price control.
New Delhi: India may mandate a cut in prices of some cancer drugs, anti-diabetics and medicines for thyroid, as the government inches closer to updating the list of essential medicines and bringing some of them under price control. The final consultation meeting of the Standing National Committee on Medicines (SNCM) with the stakeholders for revision of NLEM (National List of Essential Medicines) 2015 will be held on Monday. The committee will
- FONT SIZEAbcSmallAbcMediumAbcLarge
ET
Uh-oh! This is an exclusive story available for selected readers only.
Worry not. You’re just a step away.
Get Unlimited Access to The Economic Times
Why ?
Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors
Stock analysis. Market Research. Industry Trends on 4000+ Stocks
Clean experience with
Minimal AdsComment & Engage with ET Prime community Exclusive invites to Virtual Events with Industry Leaders A trusted team of Journalists & Analysts who can best filter signal from noise Get 1 Year Complimentary Subscription of TOI+ worth Rs.799/-
